Vertex Pharmaceuticals (VRTX) closed at $489.43 in the latest trading session, marking a +0.84% move from the prior day.

Investing in biotech stocks isn't for everyone. An unsuccessful clinical trial can cause a huge decline. The competition is ...

LONDON, August 07, 2024--Vertex Pharmaceuticals (Nasdaq: VRTX) announced today a reimbursement agreement with NHS England for eligible transfusion-dependent beta thalassemia (TDT) patients to ...

BMO Capital Markets managing director of biopharma equity research Evan Seigerman joins Market Domination to discuss the best ...

Vertex Pharmaceuticals (NASDAQ: VRTX) hasn't witnessed the crazy price spike that some other stocks have had in the new bull ...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, June 13, 2024 (GLOBE NEWSWIRE) -- Vortex Energy Corp. (CSE ...

After hours: September 18 at 7:59 PM EDT ...

I think he will be the right leader in terms of communication and vision because he's already very well known and liked within the organization," Sherman tells Yahoo Finance ... and Vertex (VRTX) as ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.